The Manchester BRC and CRF have been chosen as one of 13 centres around England which will contribute to the new NIHR BioResource for Translational Research in Common and Rare Diseases.
A new study published today has found a way to identify men with locally advanced prostate cancer who are less likely to respond well to radiotherapy.
The Public Programmes Team are running free Patient and Public Involvement (PPI) advice sessions for BRC and CRF researchers working in the areas of cancer, dermatology and musculoskeletal research.
This interactive workshop is an opportunity to learn more about the use of data to predict health risks and outcomes for clinical pathway redesign and disease prevention.
The NIHR Manchester BRC, in collaboration with the NIHR Manchester Clinical Research Facility (CRF) and supported by Corridor Manchester and Health Innovation Manchester is investing in the next generation of NHS researchers and want you to be part of it!
At the start of the year a panel of international experts from academia and industry visited Manchester for the first annual strategy workshop.
The Public Programmes team at Manchester University NHS Foundation Trust - who lead the involvement and engagement work for the NIHR Manchester Biomedical Research Centre and Clinical Research Facility - has been selected as one of ten organisations in the UK to become a test-bed for this work.
Over 150 delegates gathered in Manchester last week to hear about the work of the four northern NIHR Biomedical Research Centres (BRCs).